Topic: Latisse

The pharmaceutical product Latisse, endorsed by Brooke Shields, is marketed as an FDA-approved treatment for inadequate eyelashes. The product's side effects include potential permanent darkening of the iris and eyelid skin, leading to criticism of the pharmaceutical industry's focus on cosmetic enhancements.

Further examination of the Latisse (bimatoprost) commercial reveals warnings about permanent brown iris pigmentation and itchy eyes. The hosts mock the absurdity of risking permanent eye color changes for longer eyelashes.